{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T22:41:00Z","timestamp":1778971260974,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["IN-US-33701897"],"award-info":[{"award-number":["IN-US-33701897"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jsat.2019.11.001","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T11:28:02Z","timestamp":1573039682000},"page":"23-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["\u201cTake Charge, Get Cured\u201d: Pilot testing a targeted mHealth treatment decision support tool for methadone patients with hepatitis C virus for acceptability and promise of efficacy"],"prefix":"10.1016","volume":"109","author":[{"given":"Amy B.","family":"Jessop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Bauerle","family":"Bass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Brajuha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Alhajji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhamed Tahar","family":"Gashat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Wellington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Ventriglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennie","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"D'Avanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2019.11.001_bb0005","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","author":"AASLD\/IDSA HCV Guidance Panel","year":"2015","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.jsat.2019.11.001_bb0010","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1086\/588297","article-title":"Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994\u20132004","volume":"46","author":"Amon","year":"2008","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"10.1016\/j.jsat.2019.11.001_bb0015","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.pec.2018.07.007","article-title":"Take charge, get cured: The development and user testing of a culturally tailored mHealth decision tool on HCV treatment initiation for methadone patients","volume":"101","author":"Bass","year":"2018","journal-title":"Patient Education and Counseling"},{"key":"10.1016\/j.jsat.2019.11.001_bb0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2015.06.007","article-title":"Hepatitis C treatment turned me around: Psychological and behavioral transformation related to hepatitis C treatment","volume":"153","author":"Batchelder","year":"2015","journal-title":"Journal of Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.001_bb0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pec.2009.05.012","article-title":"Validation of a preparation for decision making scale","volume":"78","author":"Bennett","year":"2010","journal-title":"Patient Education and Counseling"},{"issue":"4","key":"10.1016\/j.jsat.2019.11.001_bb0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/10826080903452538","article-title":"Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection","volume":"45","author":"Canfield","year":"2010","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.jsat.2019.11.001_bb1000","series-title":"Division of viral hepatitis","article-title":"U.S. 2014 surveillance data for viral hepatitis, statistics and surveillance","author":"Centers for Disease Control and Prevention","year":"2016"},{"key":"10.1016\/j.jsat.2019.11.001_bb0040","author":"Center for Health Law and Policy Innovation of Harvard Law School (CHLPI)"},{"issue":"12","key":"10.1016\/j.jsat.2019.11.001_bb0055","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"The Lancet Global Health"},{"key":"10.1016\/j.jsat.2019.11.001_bb0060","doi-asserted-by":"crossref","unstructured":"Dore, G.J., Altice, F., Litwin, A.H., Dalgard, O., Gane, J., Shibolet, O., \u2026 Platt, H.L. C-EDGE CO-STAR Study Group. (2016). Elbasvir\u2013Grazoprevir to treat hepatitis C virus infection in persons receiving opioid agonist therapy: A randomized trial. Annals of Internal Medicine, 165 (9), 625\u2013634. doi:https:\/\/doi.org\/10.7326\/M16-0816.","DOI":"10.7326\/M16-0816"},{"key":"10.1016\/j.jsat.2019.11.001_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","article-title":"A survey of adverse events in 11, 241 patients with chronic viral hepatitis treated with alfa interferon","volume":"24","author":"Fattovich","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.jsat.2019.11.001_bb0070","author":"Food and Drug Administration"},{"issue":"8","key":"10.1016\/j.jsat.2019.11.001_bb0075","first-page":"21","article-title":"A mobile health intervention to improve hepatitis C outcomes among people with opioid use disorder: Protocol for a randomized controlled trial","author":"Hochstatter","year":"2019","journal-title":"Journal of Medical Internet Research"},{"issue":"4","key":"10.1016\/j.jsat.2019.11.001_bb0080","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1353\/hpu.2019.0094","article-title":"Perceptions of barriers and benefits of HCV treatment and correlates to treatment intention in methadone patients","volume":"30","author":"Jessop","year":"2019","journal-title":"J Healthcare Poor Underserved"},{"issue":"3","key":"10.1016\/j.jsat.2019.11.001_bb0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/ADM.0000000000000296","article-title":"Variation in the viral hepatitis and HIV testing policies and practices of methadone maintenance programs","volume":"11","author":"Jessop","year":"2017","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2019.11.001_bb0090","first-page":"1246A","article-title":"Viral hepatitis epidemiology and screening policies, practices inpublic medically-assisted drug treatment programs","volume":"52","author":"Jessop","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.001_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-017-0197-3","article-title":"Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China","volume":"14","author":"Li","year":"2017","journal-title":"Harm Reduction Journal"},{"issue":"10","key":"10.1016\/j.jsat.2019.11.001_bb0100","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/cid\/ciw111","article-title":"Rising mortality associated with hepatitis C virus in the United States","volume":"62","author":"Ly","year":"2016","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.001_bb0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2893.2010.01411.x","article-title":"Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance","volume":"19","author":"Martinez","year":"2012","journal-title":"Journal of Viral Hepatitis"},{"issue":"10","key":"10.1016\/j.jsat.2019.11.001_bb0110","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.2105\/AJPH.2013.301458","article-title":"A randomized trial of a hepatitis care coordination model in methadone maintenance treatment","volume":"103","author":"Masson","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.jsat.2019.11.001_bb0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10900-007-9083-3","article-title":"Limited uptake of hepatitis C treatment among injection drug users","volume":"33","author":"Mehta","year":"2008","journal-title":"Journal of Community Health"},{"key":"10.1016\/j.jsat.2019.11.001_bb0125","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1525-1497.2005.0161.x","article-title":"Barriers to the treatment of hepatitis C","volume":"20","author":"Morrill","year":"2005","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2019.11.001_bb3000","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2296-7-21","article-title":"The single item literacy screener: Evaluation of a brief instrument to identify limited reading ability","volume":"7","author":"Morris","year":"2006","journal-title":"BMC Family Practice"},{"issue":"2","key":"10.1016\/j.jsat.2019.11.001_bb0130","doi-asserted-by":"crossref","DOI":"10.2196\/10313","article-title":"Hepatitis C prevalence and management among patients receiving opioid substitution treatment in general practice in Ireland: Baseline data from a feasibility study","volume":"7","author":"Murtagh","year":"2018","journal-title":"Interactive Journal of Medical Research"},{"issue":"6","key":"10.1016\/j.jsat.2019.11.001_bb0135","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1360-0443.2008.02188.x","article-title":"Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients","volume":"103","author":"Novick","year":"2008","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.001_bb2000","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0272989X9501500105","article-title":"Validation of a decisional conflict scale","volume":"15","author":"O'Connor","year":"1995","journal-title":"Medical Decision Making"},{"issue":"4","key":"10.1016\/j.jsat.2019.11.001_bb0140","first-page":"23","article-title":"Risk of hepatitis C virus infection among heroin and methamphetamine users","volume":"21","author":"Okruhlica","year":"2019","journal-title":"Heroin Addiction & Related Clinical Problems"},{"issue":"3","key":"10.1016\/j.jsat.2019.11.001_bb0145","first-page":"47","article-title":"Difficulties in initiating hepatitis C treatment in patients with opioid usdisorder: Patient's perspective","volume":"21","author":"Palma-\u00c1lvarez","year":"2019","journal-title":"Heroin Addiction and Related Clinical Problems"},{"issue":"320","key":"10.1016\/j.jsat.2019.11.001_bb4000","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/01621459.1967.10500925","article-title":"Rank analysis of covariance","volume":"62","author":"Quade","year":"1967","journal-title":"Journal of the American Statistical Association"},{"issue":"3","key":"10.1016\/j.jsat.2019.11.001_bb0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/02791072.2009.10400539","article-title":"Premature discharge from methadone treatment: Patient perspectives","volume":"41","author":"Reisinger","year":"2009","journal-title":"Journal of Psychoactive Drugs"},{"issue":"12","key":"10.1016\/j.jsat.2019.11.001_bb0160","first-page":"1551","article-title":"HIV And HCV infection among opiate-dependent patients and methadone doses: The PROTEUS study","volume":"29","author":"Roncero","year":"2017","journal-title":"AIDS Care-Psychological and Socio-Medical Aspects of AIDS\/HIV"},{"key":"10.1016\/j.jsat.2019.11.001_bb0165","doi-asserted-by":"crossref","unstructured":"Roncero, C., Ryan, P., Littlewood, R., Mac\u00edas, J., Ruiz, J., Seijo, P., \u2026 Vega, P. (2018). Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder. Hepatic Medicine: Evidence and Research, Volume 11, 1\u201311. doi:https:\/\/doi.org\/10.2147\/hmer.s187133","DOI":"10.2147\/HMER.S187133"},{"issue":"7","key":"10.1016\/j.jsat.2019.11.001_bb0170","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/01634370802609049","article-title":"Mistrust and self-isolation: Barriers to social support for older adult methadone clients","volume":"52","author":"Smith","year":"2009","journal-title":"Journal of Gerontological Social Work"},{"issue":"4","key":"10.1016\/j.jsat.2019.11.001_bb0175","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jsat.2012.08.007","article-title":"Concurrent group treatment for hepatitis C: Implementation and outcomes in a methadone maintenance treatment program","volume":"43","author":"Stein","year":"2012","journal-title":"Journal of substance abuse treatment"},{"issue":"12","key":"10.1016\/j.jsat.2019.11.001_bb0180","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/apc.2010.0142","article-title":"Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: A qualitative exploration","volume":"24","author":"Swan","year":"2010","journal-title":"AIDS Patient Care and STDs"},{"issue":"3","key":"10.1016\/j.jsat.2019.11.001_bb0185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jsat.2005.06.002","article-title":"The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone","volume":"29","author":"Sylvestre","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2019.11.001_bb0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/cid\/ciy899","article-title":"Integrated, co-located, telemedicine-based treatment approaches for Hepatitis C virus management in opioid use disorder patients on Methadone","volume":"69","author":"Talal","year":"2019","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2019.11.001_bb0195","author":"The Ottawa Hospital Research Institute"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.001_bb0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/09687630600997527","article-title":"Valuing methadone takeaway doses: The contribution of service-user perspectives to policy and practice","volume":"14","author":"Treloar","year":"2007","journal-title":"Drugs education, prevention, and policy"},{"key":"10.1016\/j.jsat.2019.11.001_bb0205","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1365-2893.2009.01250.x","article-title":"Uptake and delivery of hepatitis C treatment in opiate substitution treatment: Perceptions of clients and health professionals","volume":"17","author":"Treloar","year":"2010","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.jsat.2019.11.001_bb0210","author":"U.S. Centers for Disease Control and Prevention"},{"issue":"4","key":"10.1016\/j.jsat.2019.11.001_bb0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/ADM.0000000000000041","article-title":"Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance","volume":"8","author":"Zeremski","year":"2014","journal-title":"Journal of Addiction Medicine"},{"issue":"44","key":"10.1016\/j.jsat.2019.11.001_bb0220","doi-asserted-by":"crossref","first-page":"7846","DOI":"10.3748\/wjg.v19.i44.7846","article-title":"Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care","volume":"19","author":"Zeremski","year":"2013","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1016\/j.jsat.2019.11.001_bb0225","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/ADM.0b013e31825f491b","article-title":"Perceived barriers to hepatitis C therapy for patients receiving opioid agonist treatment","volume":"6","author":"Zickmund","year":"2012","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2019.11.001_bb0230","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4254\/wjh.v8.i3.139","article-title":"Advances in hepatitis C therapy: What is the current state - What come's next?","volume":"8","author":"Zopf","year":"2016","journal-title":"World Journal of Hepatology"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219303769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219303769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:49:44Z","timestamp":1760039384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547219303769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":45,"alternative-id":["S0740547219303769"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2019.11.001","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cTake Charge, Get Cured\u201d: Pilot testing a targeted mHealth treatment decision support tool for methadone patients with hepatitis C virus for acceptability and promise of efficacy","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2019.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}